CRI Worldwide, 1113 Hospital Dr. Suite 202, is a clinical research site located in Willingboro, New Jersey, United States 08046.
Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
CRI Worldwide, 1113 Hospital Dr. Suite 202, has participated in 1 clinical trials.
Therapeutic areas: Schizophrenia Disorders.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Willingboro
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CRI Worldwide, 1113 Hospital Dr. Suite 202, has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CRI Worldwide, 1113 Hospital Dr. Suite 202, has 1 clinical trials on record. Their work covers Schizophrenia Disorders.
CRI Worldwide, 1113 Hospital Dr. Suite 202, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.